Erratum: Hepatocyte growth factor production is stimulated by gangliosides and TGF-β isoforms in human glioma cells (Journal of Neuro-Oncology (2007) 85 (33-38) DOI: 10.1007/s11060-007-9387-2);Hepatocyte growth factor production is stimulated by gangliosides and TGF-β isoforms in human glioma cells

Journal of Neuro-Oncology

Volumn 85, Issue 1, 2007, Pages 33-38

  Chu, Sheng Hua ^a   Ma, Yan Bin ^a   Zhang, Hong ^a   Feng, Dong Fu ^a   Zhu, Zhi An ^a   Li, Zhi Qiang ^b   Yuan, Xian Hou ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Gangliosides; Glioma; Growth factors; Hepatocyte growth factor

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GANGLIOSIDE GT 1B; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PROTEIN FUNCTION; PROTEIN SECRETION; TUMOR VASCULARIZATION;

EID: 34548725124     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0120-1     Document Type: Erratum

References (51)

1. Chu SH, Yuan XH, Jiang PC, Li ZQ, Zhang J, Wen ZH, Zhao SY, Chen XJ, Cao CJ (2005) The expression of hepatocyte growth factor and its receptor in brain astromas. Zhonghua Yi Xue Za Zhi 85:835-838
2. Chu SH, Yuan XH, Jiang PC, Zhang J, Li ZQ, Cao CJ, Wen ZH (2005) Expression of hepatocyte growth factor and its receptor mRNA in brain astrocytomas. Tumor 25:173-176
3. Chu SH, Yuan XH, Jiang PC, Li ZQ, Wen ZH (2005) The relevance of HGF, c-Met, PCNA and CD34 with glioma malignant degree and prognosis. Chin J Neuromed 4:1208-1212
4. Chu SH, Yuan XH, Jiang PC, Li ZQ, Zhang J, Wen ZH (2005) Recombinant human hepatocyte growth factor in cellular apoptosis of glioma induced by mitomycin C. Chin J Neuromed 4:1093-1096
5. Jiang PC, Chu SH, Yuan XH (2006) The c-metprotoncogene antisense oligodeoxynucleotide enhances the sensitivity of glioma cell U251 to mitomycin C. Chin J Exp Surg 23:540-542
6. Chu SH, Zhu ZA, Yuan XH, Li ZQ, Jiang PC (2006) In vitro and in vivo potentiating the cytotoxic effect of radiation on human U251 gliomas by the c-Met antisense oligodeoxynucleotides. J Neurooncol 80:143-149
7. Chu SH, Yuan XH, Li ZQ, Jiang PC, Zhang J (2006) C-Met antisense oligodeoxynucleotide inhibits growth of glioma cells. Surg Neurol 65:533-538
8. Chu SH, Zhang H, Ma YB, Feng DF, Yuan XH, Li ZQ (2007) C-Met antisense oligodeoxynucleotides as a novel therapeutic agent for glioma: In vitro and in vivo studies of uptake, effects and toxicity. J Surg Res 137 (in press)
9. Abounader R, Laterra J (2005) Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro-oncol 7:436-451
10. Karcher S, Steiner HH, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, Unterberg A, Herold-Mende C (2006) Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer 118:2182-2189
11. Chattopadhyay N, Tfelt-Hansen J, Brown EM (2002) PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells. Brain Res Mol Brain Res 102:73-82
12. Chattopadhyay N, Butters RR, Brown EM (2001) Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. Brain Res Mol Brain Res 87:100-108
13. Guerin C, Luddy C, Abounader R, Lal B, Laterra J (2000) Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor. Biochem Biophys Res Commun 273:287-293
14. Lux A, Salway F, Dressman HK, Kroner-Lux G, Hafner M, Day PJ, Marchuk DA, Garland J (2006) ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression. BMC Cardiovasc Disord 6:13
15. Xiong B, Gong LL, Zhang F, Hu MB, Yuan HY (2002) TGF beta1 expression and angiogenesis in colorectal cancer tissue. World J Gastroenterol 8:496-498
16. Ren RF, Lah JJ, Diehlmann A, Kim ES, Hawver DB, Levey AI, Beyreuther K, Flanders KC (1999) Differential effects of transforming growth factor-beta(s) and glial cell line-derived neurotrophic factor on gene expression of presenilin-1 in human post-mitotic neurons and astrocytes. Neuroscience 93:1041-1049
17. Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A (1992) Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. J Immunol 148:1404-1410
18. Stiles JD, Ostrow PT, Balos LL, Greenberg SJ, Plunkett R, Grand W, Heffner RR Jr (1997) Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas. J Neuropathol Exp Neurol 56:435-439
19. Koochekpour S, Merzak A, Pilkington GJ (1996) Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett 102:209-215
20. Eisele G, Wischhusen J, Mittelbronn M, Meyermann R, Waldhauer I, Steinle A, Weller M, Friese MA (2006) TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Brain 129:2416-2425
21. Nabors LB, Gillespie GY, Harkins L, King PH (2001) HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 61:2154-2161
22. Wick W, Platten M, Weller M (2001) Glioma cell invasion: Regulation of metalloproteinase activity by TGF-beta. J Neurooncol 53:177-185
23. Brockmann MA, Ulbricht U, Gruner K, Fillbrandt R, Westphal M, Lamszus K (2003) Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors. Neurosurgery 52:1391-1399
24. Mennel HD, Lell B (2005) Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors. Clin Neuropathol 24:13-18
25. Kawai K, Takahashi H, Watarai S, Ishizu H, Fukai K, Tanabe Y, Nose S, Kuroda S (1999) Occurrence of ganglioside GD3 in neoplastic astrocytes An immunocytochemical study in humans. Virchows Arch 434:201-205
26. Abate LE, Mukherjee P, Seyfried TN (2006) Gene-linked shift in ganglioside distribution influences growth and vascularity in a mouse astrocytoma. J Neurochem 98:1973-1984
27. Noll EN, Lin J, Nakatsuji Y, Miller RH, Black PM (2001) GM3 as a novel growth regulator for human gliomas. Exp Neurol 168:300-309
28. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Nakano H, Matsumoto K, Nakamura T, Ogihara T (1996) Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: Additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens 14:1067-1072
29. Shimao Y, Nabeshima K, Inoue T, Koono M (1999) Role of fibroblasts in HGF/SF-induced cohort migration of human colorectal carcinoma cells: fibroblasts stimulate migration associated with increased fibronectin production via upregulated TGF-beta1. Int J Cancer 82:449-458
30. Nishimura K, Kitamura M, Miura H, Nonomura N, Takada S, Takahara S, Matsumoto K, Nakamura T, Matsumiya K (1999) Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction. Prostate 41:145-153
31. Nishimura K, Takada S, Miura H, Tsujimura A, Kitamura M, Nonomura N, Matsumiya K, Okuyama A (2000) Role of hepatocyte growth factor in invasion of prostate cancer cell lines through tumor-stromal interaction. Hinyokika Kiyo 46:769-774
32. Byers S, Park M, Sommers C, Seslar S (1994) Breast carcinoma: A collective disorder. Breast Cancer Res Treat 31:203-215
33. Shibamoto S, Hayakawa M, Hori T, Oku N, Miyazawa K, Kitamura N, Ito F (1992) Hepatocyte growth factor and transforming growth factor-beta stimulate both cell growth and migration of human gastric adenocarcinoma cells. Cell Struct Funct 17:185-190
34. Urba ska-Rys H, Wierzbowska A, Robak T (2003) Circulating angiogenic cytokines in multiple myeloma and related disorders Eur Cytokine Netw 14:40-51
35. Vasir B, Reitz P, Xu G, Sharma A, Bonner-Weir S, Weir GC (2000) Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-alpha, TGF-beta, bFGF and Vimentin) in cultured and transplanted rat islets. Diabetologia 43:763-772
36. Pacuszka T, Bradley RM, Fishman PH (1991) Neoglycolipid analogues of ganglioside GM1 as functional receptors of cholera toxin. Biochemistry 30:2563-2570
37. Sinha M, Mishra S, Joshi PG (2003) Liquid-ordered microdomains in lipid rafts and plasma membrane of U-87 MG cells: A time-resolved fluorescence study. Eur Biophys J 32:381-391
38. Clarke TM, Pilkington GJ (1992) Influence of serum on growth factor control of surface ganglioside expression in cultured neoplastic glial clones. Br J Neurosurg 6:85
39. Knott JCA, Edwards AJ, Gullan RW, Clarke TM, Pilkington GJ (1990) A human glioma cell line retains expression of GFAP and gangliosides recognised by A2BS and LB1 antibodies, after prolonged passage. Neuropathol Appl Neurobiol 16:489-500
40. Merzak A, Koochekpour S, Pilkington GJ (1995) Gangliosides modulate proliferation, migration and invasion of human brain tumour cells in vitro. Mol Chem Neuropathol 24:121-135
41. Koochekpour S, Merzak A, Pilkington GJ (1995) Growth factors and gangliosides stimulate laminin production by human glioma cells in vitro. Neurosci Lett 186:53-56
42. Maidment LS, Merzak A, Koochekpour S, Rooprai HK, Rucklidge GJ, Pilkington GJ (1996) The effect of exogenous gangliosides on matrix metalloproteinase secretion by human glioma cells in vitro. Eur J Cancer 32A:868-871
43. Ziche M, Alessandri G, Gulhno PM (1989) Gangliosides promote the angiogenic response. Lab Invest 61:629-634
44. De Cristan G, Morbidelli L, Alessandri G, Ziche M, Cappa AP, Gullino PM (1990) Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium. J Cell Physiol 144:505-510
45. Alessandri G, Filippeschi S, Sinibaldi P, Momet F, Passera P, Spreafico F, Cappa PM, Gullino PM (1987) Influence of gangliosides on primary and me&static neoplastic growth in human and murine cells. Cancer Res 47:4243-4247
46. Manfredi MG, Lim S, Claffey KP, Seyfried TN (1999) Gangliosides influence angiogenesis in an experimental mouse brain tumor. Cancer Res 59:5392-5397
47. Ziche M, Morbidelli L, Alessandri G, Gullino PM (1992) Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. Lab Invest 67:711-715
48. Shinoura N, Dohi T, Kondo T, Yoshioka M, Takakura K, Oshima M (1992) Ganglioside composition and its relation to clinical data in brain tumours. Neurosurgery 31:541-549
49. Gaini SM, Riboni L, Cerri C, Grimoldi N, Sganzerla EP, Berra B (1988) Ganglioside content and composition in human gliomas. Acta Neurochir. Suppl Wien 43:126-129
50. Fredman P, von Hoist H, Collins VP, Dellheden B, Svennerholm L (1993) Expression of gangliosides GD3 and 3′-isoLM1 in autopsy brains from patients with malignant tumors. J Neurochem 60:99-105
51. Koochekpour S, Pilkington GJ (1996) Vascular and perivascular GD3 expression in human glioma. Cancer Lett 104:97-102